.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
US Army
Chinese Patent Office
Mallinckrodt
Deloitte
Cantor Fitzgerald
Julphar
Fuji
Johnson and Johnson

Generated: September 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Disinfectant delivery system and method of providing alcohol-free disinfection
Abstract: A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body. When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure.
Inventor(s): Hanifl; Paul H. (Barrington Hills, IL), Keaty; Thomas (Crystal Lake, IL), Skiba; Barbara T. (Chicago, IL)
Assignee: Sage Products, Inc. (Cary, IL)
Application Number:12/245,362
Patent Claims: 1. A method of infection reduction by preparation of a patient before an invasive procedure, comprising a. providing a first blended cloth comprising a fibrous mat impregnated with a first disinfecting solution having chlorohexidine gluconate (CHG) as an active ingredient and having no alcohol, and b. using the first impregnated cloth to disinfect at least a portion of the patient at least one day prior to, and up to several days prior to, the invasive procedure proximate the invasive procedure, c. providing a second blended cloth comprising a fibrous mat impregnated with a second disinfecting solution having chlorohexidine gluconate (CHG) as an active ingredient and having no alcohol, and d. using the second impregnated cloth to disinfect at least a portion of the patient immediately prior to the invasive procedure proximate the invasive procedure, wherein the first blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said first blended cloth having an absorbency by weight greater than the weight of said first blended cloth, and wherein the second blended cloth comprises first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of the second fibers, said second blended cloth having an absorbency by weight greater than the weight of said second blended cloth.

2. The method according to claim 1, in which the first fibers of the first blended cloth comprise polyester fibers.

3. The method according to claim 1, in which the second fibers of the first blended cloth comprise polyester fibers.

4. The method according to claim 1, in which the first fibers of the second blended cloth comprise polyester fibers.

5. The method according to claim 1, in which the second fibers of the second blended cloth comprise polyester fibers.

6. The method according to claim 1, wherein substantially all of the CHG in the first disinfecting solution is released from the first blended cloth during the method step "b".

7. The method according to claim 1, wherein substantially all of the CHG in the second disinfecting solution is released from the second blended cloth during the method step "d".
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chinese Patent Office
Moodys
Boehringer Ingelheim
Dow
QuintilesIMS
Medtronic
AstraZeneca
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot